Related Experiment Video
Updated: Jul 19, 2026

Models of Bone Metastasis
Published on: September 4, 2012
Biology of bone cancer pain
Michael J Goblirsch1, Pawel P Zwolak, Denis R Clohisy
1Department of Orthopaedic Surgery, The University of Minnesota, Minneapolis, Minnesota 55455, USA.
Abstract:
Bone cancer pain is a devastating manifestation of metastatic cancer. Unfortunately, current therapies can be ineffective, and when they are effective, the duration of the patient's survival typically exceeds the duration of pain relief. New, mechanistically based therapies are desperately needed. Study of experimental animal models has provided insight into the mechanisms that drive bone cancer pain and provides an opportunity for developing targeted therapies. Mechanisms that drive bone cancer pain include tumor-directed osteoclast-mediated osteolysis, tumor cells themselves, tumor-induced nerve injury, stimulation of transient receptor potential vanilloid type 1 ion channel, endothelin A, and host cell production of nerve growth factor. Current and future therapies include external beam radiation, osteoclast-targeted inhibiting agents, anti-inflammatory drugs, transient receptor potential vanilloid type 1 antagonists, and antibody therapies that target nerve growth factor or tumor angiogenesis. It is likely that a combination of these therapies will be superior to any one therapy alone.
Insights
Bone cancer pain management is challenging due to ineffective treatments. Research in animal models reveals key pain mechanisms, guiding development of targeted therapies for better patient outcomes.
Area of Science:
- Oncology
- Pain Management
- Cancer Metastasis
Background:
- Bone cancer pain is a severe complication of metastatic cancer.
- Current treatments often provide inadequate or short-lived pain relief.
- There is a critical need for novel, mechanistically informed therapies.
Purpose of the Study:
- To investigate the underlying mechanisms of bone cancer pain using experimental animal models.
- To identify potential therapeutic targets for managing bone cancer pain.
Main Methods:
- Utilized experimental animal models to study bone cancer pain mechanisms.
- Identified key factors contributing to pain, including osteolysis, tumor cells, nerve injury, and specific molecular pathways.
Main Results:
- Identified multiple mechanisms driving bone cancer pain: osteoclast-mediated osteolysis, tumor cells, nerve injury, transient receptor potential vanilloid type 1 (TRPV1) ion channel stimulation, endothelin A, and nerve growth factor (NGF).
Conclusions:
- Understanding these mechanisms provides a basis for developing targeted therapies.
- Future treatments may involve combinations of radiation, osteoclast inhibitors, anti-inflammatories, TRPV1 antagonists, and antibody therapies targeting NGF or tumor angiogenesis.
Related Concept Videos
Blood and Nerve Supply to the Bones
Nutrient Artery
The nutrient artery is the main blood vessel that enters the diaphysis via the nutrient foramen. While most long bones have only one nutrient foramen, large bones, such as the femur, may have two. This...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling
Osteoclasts in Bone Remodeling
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Nociception

